Net Cash Provided by (Used in) Operating Activities |
-558K |
USD |
-18.8% |
Q4 2023 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
200K |
USD |
|
Q4 2023 |
Q1 2024 |
Common Stock, Shares Authorized |
300M |
shares |
0% |
Q2 2024 |
Q3 2024 |
Common Stock, Shares, Issued |
53.2M |
shares |
0% |
Q2 2024 |
Q3 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q3 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-358K |
USD |
+23.9% |
Q4 2023 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
841K |
USD |
+70.5% |
Q2 2024 |
Q3 2024 |
Deferred Tax Assets, Valuation Allowance |
12M |
USD |
+4.25% |
Q3 2023 |
FY 2023 |
Deferred Tax Assets, Gross |
12M |
USD |
+4.25% |
Q3 2023 |
FY 2023 |
Depreciation |
3.59K |
USD |
-8.48% |
Q4 2023 |
Q1 2024 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
-3.4M |
USD |
-38% |
Q2 2024 |
Q3 2024 |
Property, Plant and Equipment, Gross |
150K |
USD |
-89.6% |
Q2 2024 |
Q3 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
8.47M |
USD |
+6.16% |
Q3 2023 |
FY 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2024 |
Q3 2024 |
Preferred Stock, Shares Authorized |
1M |
shares |
0% |
Q2 2024 |
Q3 2024 |
Unrecognized Tax Benefits |
0 |
USD |
|
Q3 2023 |
FY 2023 |
Additional Paid in Capital |
83.5M |
USD |
+0.94% |
Q2 2024 |
Q3 2024 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2024 |
Q3 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
1.39K |
USD |
-12.1% |
Q3 2023 |
FY 2023 |
Share-based Payment Arrangement, Expense |
23.2K |
USD |
-72.8% |
Q4 2023 |
Q1 2024 |
Preferred Stock, Par or Stated Value Per Share |
0.1 |
USD/shares |
0% |
Q2 2024 |
Q3 2024 |